Kelly James Patrick

Avg. Two Year Performance

92% Avg. Purchase Return
39% Compound
(14%) Avg. Sale Return
(7%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(15%)(20%)(21%)(26%)92%
Purchase Success Rate0 of 10 of 10 of 10 of 11 of 1
Average Sale Return6%8%6%3%(14%)
Sale Success Rate9 of 117 of 116 of 115 of 112 of 11
Drugs » Biotechnology

EVP, CFO and Treasurer:

Holdings: 14.43K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

EVP & Chief Financial Officer:

Holdings: 186.87K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Executive Vice-President & CFO:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--